Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study
Hira Mian, Tanya M. Wildes, Ravi Vij, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Multiple myeloma
Florent Malard, Paola Neri, Nizar J. Bahlis, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 39
International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma
Luciano J. Costa, Rahul Banerjee, Hira Mian, et al.
Leukemia (2025)
Open Access | Times Cited: 2
Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review
Nina Rosa Neuendorff, Abdullah Khan, Fabian Ullrich, et al.
Journal of Geriatric Oncology (2024) Vol. 15, Iss. 3, pp. 101734-101734
Open Access | Times Cited: 9
Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study
Arleigh McCurdy, Hsien Seow, Gregory R. Pond, et al.
Haematologica (2023) Vol. 108, Iss. 12, pp. 3384-3391
Open Access | Times Cited: 13
Novel Treatment Options for Multiple Myeloma
Andrew J. Portuguese, Rahul Banerjee, Gui Zhen Chen, et al.
JCO Oncology Practice (2025)
Closed Access
Multiple Myeloma: Improved Outcomes Resulting from a Rapidly Expanding Number of Therapeutic Options
Susanna Kim, Adam ElSayed, Jonathan E. Moore, et al.
Targeted Oncology (2025)
Closed Access
Evaluation of claims-based frailty measurements in older patients with cancer: a retrospective cohort study
Hirooka Kayo, Yusuke Kanno, Itoh Sakiko, et al.
Age and Ageing (2025) Vol. 54, Iss. 2
Closed Access
PMEPA1 Binds NEDD4L to Inhibit the Malignant Progression of Multiple Myeloma by Inactivating Wnt/β-Catenin Signaling
Shanshan Hu, Xinfang Gao, Yan Zhu, et al.
Cell Biochemistry and Biophysics (2025)
Open Access
Expert Perspectives on Current Challenges and Emerging Approaches for Multiple Myeloma: Narrative Review of an Inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma
Ajai Chari, Susan Bal, Sikander Ailawadhi, et al.
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)
Imran Haider, Darryl P. Leong, Martha L Louzada, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 8, pp. 1167-1174
Closed Access | Times Cited: 3
Personalized Treatment of Multiple Myeloma in Frail Patients
Jodi J. Lipof, Nadine Abdallah, Brea Lipe
Current Oncology Reports (2024) Vol. 26, Iss. 7, pp. 744-753
Closed Access | Times Cited: 2
Hematological Malignancies in Older Patients: Focus on the Potential Role of a Geriatric Assessment Management
Santino Caserta, Gabriella Cancemi, Silverio Loreta, et al.
Diagnostics (2024) Vol. 14, Iss. 13, pp. 1390-1390
Open Access | Times Cited: 2
A roadmap towards improving outcomes in multiple myeloma
Mohamad Mohty, Thierry Façon, Florent Malard, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Daratumumab Treatment for “Truly Frail” Elderly Myeloma Patients
Yuichi Horigome, Kazuhito Suzuki, Takahiro Suzuki
Life (2024) Vol. 14, Iss. 3, pp. 389-389
Open Access | Times Cited: 1
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis
Rafael Ríos, Ramón Lecumberri, María Teresa Cibeira, et al.
(2024)
Open Access | Times Cited: 1
Recommendations for the effective use of T-cell–redirecting therapies: a Canadian consensus statement
Guido Lancman, Kevin Song, Darrell White, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Treatment of elderly and frail myeloma patients
Steven Chun-Min Shih, Alissa Visram, Hira Mian
La Presse Médicale (2024), pp. 104266-104266
Open Access | Times Cited: 1
The Haemato‐Oncology Frailty (HOF) score to assess frailty in lymphoma
Hena Ramdany, Thomas Lofaro, Simona Deplano
European Journal Of Haematology (2023) Vol. 112, Iss. 4, pp. 611-620
Closed Access | Times Cited: 2
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis
Rafael Ríos, Ramón Lecumberri, María Teresa Cibeira, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1689-1689
Open Access
What is the ideal approach—doublet, triplet, or quadruplet(s)?
Shaji Kumar
Hematology (2024) Vol. 2024, Iss. 1, pp. 551-560
Closed Access
Cumulative Deficits Frailty Index and Relationship Status Predict Survival in Multiple Myeloma
Shaji Kumar, Nadine Abdallah, Paul Dizona, et al.
Research Square (Research Square) (2024)
Open Access
Zelluläre Therapien im Alter: Everything, everywhere, all at once?
Wiebke Rösler
InFo Hämatologie + Onkologie (2024) Vol. 27, Iss. 7-8, pp. 20-26
Closed Access
Optimizing multiple Myeloma clinical trials: research direction, addressing limitations, and strategies for improvement
MS Ebraheem, Morie A. Gertz, Hira Mian
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-10
Closed Access
Selection determines therapeutic effects: a retrospective analysis of the application of different frailty tools in elderly patients with multiple myeloma
Yujun Li, Songying Zhao, Jianmei Xu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
LTe2 induces cell apoptosis in multiple myeloma by suppressing AKT phosphorylation at Thr308 and Ser473
Yuanjiao Zhang, Jiacheng Qian, Mingmei Jiang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top